CLINICAL TRIALS PROFILE FOR NPC-06
✉ Email this page to a colleague
Clinical Trials for NPC-06
Trial ID | Title | Status | Sponsor | Phase | Summary |
---|---|---|---|---|---|
NCT00908453 ↗ | The Study of NPC-06 - Investigation of Safety, Efficacy and Pharmacokinetics of Fosphenytoin | Completed | Nobelpharma | Phase 3 | The study is to evaluate safety, efficacy and pharmacokinetics of intravenously administered fosphenytoin in patients with neurosurgery, head trauma, epilepsy or status epilepticus who are requiring a loading dose of phenytoin. |
NCT03773055 ↗ | Phase II Clinical Trial of NPC-06 in Patients With Neuropathic Pain in Cancer | Terminated | Nobelpharma | Phase 2 | The purpose of this trial is to investigate the efficiency of pain relief and the safety of NPC-06 for the neuropathic pain associated with cancer, in addition to explore the effective concentration of NPC-06. |
NCT04139330 ↗ | NPC-06 to Acute Pain in Herpes Zoster | Terminated | Nobelpharma | Phase 2 | The purpose of this trial is to investigate the efficiency of pain relief and the safety of NPC-06 for the acute pain in herpes zoster in the placebo-controlled double-blind parallel group trial, in addition to explore the effective concentration of NPC-06. |
NCT05480553 ↗ | A Phase 3 Study of NPC-06 in Patients With Pain Associated With Acute Herpes Zoster | Not yet recruiting | Nobelpharma | Phase 3 | To confirm the pain relief effect and the safety of NPC-06 (fosphenytoin sodium hydrate) in patients with pain associated with acute herpes zoster in a placebo-controlled, double-blind, parallel-group, comparative manner. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Summary |
Clinical Trial Conditions for NPC-06
Condition Name
Clinical Trial Locations for NPC-06
Clinical Trial Progress for NPC-06
Clinical Trial Phase
Clinical Trial Sponsors for NPC-06
Sponsor Name